This inventor holds 9 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Council of Scientific and Industrial Research, Ranbaxy Laboratories, Inc.. Active years: 2000-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Uttar Pradesh, IN (2009 - 2010)
- Lucknow, IN (2000 - 2015)
Company Filing History:
5 out of 2,130 
4 out of 157 
Years Active: 2000-2015
Title: Anil Kumar Saxena: Innovator in Neuropharmacology
Introduction
Anil Kumar Saxena is a prominent inventor based in Lucknow, India. He has made significant contributions to the field of neuropharmacology, particularly in the development of therapeutic agents for neurodegenerative diseases. With a total of 9 patents to his name, Saxena's work focuses on innovative solutions for treating conditions such as Alzheimer's disease.
Latest Patents
Saxena's latest patents include groundbreaking inventions such as "Substituted 1, 2, 3, 4-tetrahydroquinolin-7-yl carbamates as acetylcholinesterase inhibitors for treatment of Alzheimer's disease." This invention relates to novel compounds that serve as therapeutic agents, particularly in the prevention and treatment of Alzheimer's disease and related memory disturbances. The compounds act as inhibitors of central cholinesterase enzymes, specifically acetylcholinesterase (AChE), following an indirect cholinomimetic pathway.
Another notable patent is "Substituted carbamic acid quinolin-6-yl esters useful as acetylcholinesterase inhibitors." This invention introduces new substituted carbamic acid quinoline-6-yl esters that exhibit potent antiacetylcholinesterase activity. These compounds have potential therapeutic applications for the prevention and treatment of acetylcholinesterase-related disorders affecting both the peripheral and central nervous systems.
Career Highlights
Throughout his career, Anil Kumar Saxena has worked with esteemed organizations such as the Council of Scientific & Industrial Research and Ranbaxy Laboratories, Inc. His experience in these institutions has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.
Collaborations
Saxena has collaborated with notable colleagues, including Nitya Anand and Neelima Sinha. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of neuropharmacology.
Conclusion
Anil Kumar Saxena's contributions to the field of neuropharmacology through his innovative patents highlight his commitment to advancing medical science. His work in developing acetylcholinesterase inhibitors showcases the potential for new therapeutic approaches to combat neurodegenerative diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile